Tag

Ibogaine

All articles tagged with #ibogaine

Trump Signs Order to Fast-Track Psychedelic Therapies for Veterans
politics1 month ago

Trump Signs Order to Fast-Track Psychedelic Therapies for Veterans

President Trump signed an executive order to accelerate research and access to psychedelic medicines—highlighting ibogaine—as potential treatments for serious mental illnesses and focusing on veterans with PTSD and suicide risk. The order directs cross‑agency collaboration (DOJ, HHS, VA, FDA), aims for faster regulatory review through science‑based pathways, and includes a $50 million federal funding commitment for ibogaine research and expanded access in licensed, hospital‑grade settings, all while maintaining rigorous safety standards.

Trump signs order to fast-track psychedelic research, including ibogaine
politics1 month ago

Trump signs order to fast-track psychedelic research, including ibogaine

President Trump signed an executive order to ease federal restrictions on psychedelic research, including ibogaine, with a $50 million funding commitment and a pathway for ibogaine to be studied and used under the FDA's Right To Try for seriously ill patients. The FDA will also add three psychedelics to the National Priority Voucher program to accelerate reviews, while maintaining oversight and not legalizing the drugs. The move aims to spur new mental-health treatments but underscores safety concerns and the need for more robust clinical trials.

White House eyes ibogaine research funding for PTSD
politics1 month ago

White House eyes ibogaine research funding for PTSD

The White House is drafting an executive order to open the door to federal funding for research on ibogaine, a psychedelic used abroad to treat PTSD and brain injuries. It would not reclassify the drug (still Schedule I) but signals support for further U.S. studies on safety and effectiveness, with a focus on veterans. Evidence is limited—mostly small observational studies—with notable cardiac risks and several deaths reported; a Stanford study suggested potential PTSD relief when ibogaine is paired with magnesium, yet more rigorous trials are needed before any medical use.

NFL and UFC Athletes Explore Psychedelics for Brain Injury Recovery
health8 months ago

NFL and UFC Athletes Explore Psychedelics for Brain Injury Recovery

A small but growing number of athletes and veterans are turning to ibogaine, a psychedelic derived from a West African shrub, for potential treatment of traumatic brain injury, PTSD, and addiction. While promising results from studies and personal testimonies suggest significant benefits, experts caution that more research and clinical trials are needed due to safety concerns and legal restrictions. The treatment is currently unregulated in the U.S., but interest and funding for further research are increasing.

Exploring Navy SEALS' Battle with PTSD and Psychedelic Therapy
health1 year ago

Exploring Navy SEALS' Battle with PTSD and Psychedelic Therapy

The documentary 'In Waves and War' explores the struggles of Navy SEALS with PTSD, addiction, and other mental health issues following deployments to Iraq and Afghanistan. It highlights the potential of psychedelic treatments like ibogaine and 5-MeO-DMT, which some veterans have found beneficial despite regulatory challenges in the U.S. The film underscores the mental health crisis among veterans and the need for alternative therapies.

"Ibogaine: The Controversial Psychedelic Treatment for U.S. Patients"
health2 years ago

"Ibogaine: The Controversial Psychedelic Treatment for U.S. Patients"

Ibogaine, a psychedelic drug derived from an African shrub, has shown promising results in treating addiction, anxiety, depression, and PTSD, particularly in Special Operations veterans with traumatic brain injuries. Despite its illegal status in the United States, advocates are pushing for access to the drug due to its potential therapeutic benefits. Safety concerns about its impact on the heart have hindered research and approval, but companies and investors are investing in developing ibogaine-derived treatments. A Stanford University study funded by tech industry leaders found that ibogaine combined with magnesium reduced symptoms of PTSD and depression in veterans, sparking interest in further research and potential approval for therapeutic use.

"Psychedelic Drug Shows Promise for Treating Opioid Addiction"
health2 years ago

"Psychedelic Drug Shows Promise for Treating Opioid Addiction"

Ibogaine, a powerful psychedelic derived from a Central African shrub, is gaining renewed attention as a potential treatment for opioid addiction. Despite its intense hallucinogenic effects and associated risks, studies have shown that a significant portion of individuals treated with ibogaine experienced effective recovery from opioid or crack cocaine addiction. The drug appears to alleviate withdrawal symptoms and cravings while instilling a newfound commitment to sobriety. However, ibogaine remains illegal in the United States, leading many patients to seek treatment at unregulated clinics abroad.

"The Truth About Ibogaine: A Guide to the Psychedelic Treatment"
health2 years ago

"The Truth About Ibogaine: A Guide to the Psychedelic Treatment"

Ibogaine is a naturally occurring psychoactive compound derived from the iboga tree, primarily found in Central Africa. It has shown promise in treating opioid addiction, PTSD, and traumatic brain injuries, with some studies indicating a high success rate in achieving sobriety after a single session. Ibogaine is illegal in the United States but is available in countries such as Mexico, Brazil, New Zealand, Canada, and South Africa for those seeking therapy.

"African Psychedelic Plant Ibogaine Shows Promise in Treating Traumatic Brain Injuries in Veterans"
health2 years ago

"African Psychedelic Plant Ibogaine Shows Promise in Treating Traumatic Brain Injuries in Veterans"

A new study has shown that ibogaine, a compound found in the African psychedelic plant Tabernanthe iboga, significantly alleviated symptoms of traumatic brain injury (TBI) in military veterans, including improving functioning, PTSD, depression, and anxiety with no adverse side effects. The study, published in Nature Medicine, involved 30 veterans and found that ibogaine, when combined with magnesium, safely and effectively reduced symptoms and improved functioning. The researchers believe that ibogaine holds broader therapeutic potential for other neuro-psychiatric conditions and are planning further studies to understand its effects on the brain.

"Psychedelic Ibogaine Shows Promise in Treating PTSD and Brain Injuries in Veterans"
health-and-medicine2 years ago

"Psychedelic Ibogaine Shows Promise in Treating PTSD and Brain Injuries in Veterans"

A small study from Stanford University suggests that ibogaine, a psychoactive drug derived from the iboga shrub, may be highly effective in treating PTSD and other symptoms stemming from traumatic brain injury (TBI) in military veterans. The study, which took place in Mexico due to ibogaine's illegal status in the US, showed significant improvements in the veterans' disabilities and mental health conditions post-treatment. However, the study's limitations, including its non-randomized, self-selected participant group and lack of a control, mean that further research is needed to confirm ibogaine's efficacy and understand its mechanisms before it can be recommended for clinical practice. The findings are published in the journal Nature Medicine.